To meet the diversified requirements of our prestigious clients, we are engaged in offering 250mg Fulvestrant Injection. The offered injection is often prescribed to treat hormone-receptor (HR) positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Our offered injection is generally given to postmenopausal women who have not been previously treated with other medicines. Moreover, this 250mg Fulvestrant Injection is usually given once every 2 weeks for the first 3 doses.
Minimum Order Quantity |
1 Box |
Packaging size |
5 ml |
Brand |
Faslodex |
Composition |
Fulvestrant |
Manufacturer |
AstraZeneca |
Usage |
Hospital |
Packaging Type |
Box |
Strength |
250mg/ 50mg |
Price:
![]() |
STRIKAR LIFESCIENCE LLP
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |